SUBSCRIBERS

GSK eyes support from Singapore, Qatar for consumer healthcare division

Published Tue, Jan 18, 2022 · 09:50 PM

    DeeperDive is a beta AI feature. Refer to full articles for the facts.

    London

    GLAXOSMITHKLINE (GSK) is spinning off its consumer healthcare division this year, and intends to seek support for the flotation from sovereign wealth funds and other major institutions.

    A report in The Telegraph on Monday (Jan 17) said that Singapore and Qatar were regarded as potential "cornerstone investors".

    Decoding Asia newsletter: your guide to navigating Asia in a new global order. Sign up here to get Decoding Asia newsletter. Delivered to your inbox. Free.

    Copyright SPH Media. All rights reserved.